Literature DB >> 767361

Diagnostic value of indirect hemagglutination in the seroepidemiology of Shigella infections.

C M Patton, E J Gangarosa, J B Weissman, M H Merson, G K Morris.   

Abstract

To evaluate the usefulness of the indirect hemagglutination (IHA) test in the epidemiological investigation of shigellosis, single serum specimens were tested from 50 patients with Shigella dysenteriae 1 (Shiga bacillus) infections, 103 asymptomatic contacts of these cases, 267 adult and 100 student control, and serum specimens collected during two outbreaks caused by S. sonnei and one outbreak due to S. flexneri 6. In patients with S. dysenteriae 1, 74% demonstrated titers of greater than or equal to 1:40, with 50% showing titers of greater than or equal to 1:160, whereas in the controls 10.4% had titers of greater than or equal to 1:40 and only 0.3% had titers of greater than or equal to 1:160. IHA titers in serum specimens collected from patients with S. sonnei and S. flexneri 6 were too low to be considered diagnostic for individual patients, but were useful in analysis of group results. Groups of ill individuals yielded titers significantly higher than non-ill groups; however, titers from ill groups were usually less than 1:40. The IHA test for S. dysenteriae 1 antibodies serves as a valuable adjunct to the diagnosis of Shiga bacillus dysentery. In our laboratory, an IHA titer of 1:40 or 1:80 is a "borderline positive." Shiga bacillus dysentery is strongly indicated when IHA titers are greater than or equal to 1:60.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 767361      PMCID: PMC274250          DOI: 10.1128/jcm.3.2.143-148.1976

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Hemagglutination test for specific antibodies in dysentery caused by Shigella sonnei.

Authors:  E NETER; J WALKER
Journal:  Am J Clin Pathol       Date:  1954-12       Impact factor: 2.493

2.  Erythrocyte-modifying capacity of Shigella dysenteriae (SHIGA) antigen and its polysaccharide component.

Authors:  E NETER; E A GORZYNSKI
Journal:  Proc Soc Exp Biol Med       Date:  1954-03

3.  Serologic response of patients with shiga dysentery.

Authors:  A Cáceres; L J Mata
Journal:  J Infect Dis       Date:  1974-04       Impact factor: 5.226

4.  The use of passive haemagglutination reaction in epidemiological practice in dysentery.

Authors:  V D Belikova-Aldakova; N F Blumel; A D Zherikova; K Z Levtova; E B Perfilyeva; N A Solovyeva; D P Sharova
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1972

5.  An outbreak of Shigella sonnei gastroenteritis on Colorado River raft trips.

Authors:  M H Merson; D A Goldmann; K M Boyer; N J Peterson; C Patton; L G Everett; H Downs; A Steckler; W H Barker
Journal:  Am J Epidemiol       Date:  1974-09       Impact factor: 4.897

6.  Utilization of differentiation of antibodies to Shigella organisms according to the immunoglobulin class in the serological diagnostics of dysentery and in study of its epidemiology.

Authors:  L B Hasenson; T Y Gennadeva; A V Lullu
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1971

7.  Epidemic Shiga bacillus dysentery in Central America. I. Etiologic investigations in Guatemala, 1969.

Authors:  L J Mata; E J Gangarosa; A Cáceres; D R Perera; M L Mejicanos
Journal:  J Infect Dis       Date:  1970-09       Impact factor: 5.226

8.  Shigella flexneri antibody levels in healthy subjects from various regions of the United States.

Authors:  V M Young; M R Lee; W C Branche; D M Kenton
Journal:  Am J Public Health Nations Health       Date:  1967-12

9.  [Indirect hemagglutination for the study of antibodies to enterobacteriaceae].

Authors:  A Cáceres; L J Mata
Journal:  Rev Latinoam Microbiol       Date:  1970 Jul-Sep

10.  Microdetermination of Shigella hemagglutinins in human and rabbit sera with monovalent and polyvalent antigens.

Authors:  K C Haltalin; B M Matteck; J D Nelson
Journal:  J Immunol       Date:  1966-10       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.